# Thalidomide in Pediatric Inflammatory Bowel Diseases.

> **NCT00720538** · PHASE3 · COMPLETED · sponsor: **IRCCS Burlo Garofolo** · enrollment: 84 (actual)

## Conditions studied

- Inflammatory Bowel Diseases
- Crohn's Disease
- Ulcerative Colitis

## Interventions

- **DRUG:** Thalidomide
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00720538
- **Lead sponsor:** IRCCS Burlo Garofolo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2011-09
- **Final completion:** 2012-06
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2012-10-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00720538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00720538, "Thalidomide in Pediatric Inflammatory Bowel Diseases.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00720538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*